Home › NDC Lookup › RxCUI directory › RxCUI 828320

Cyclobenzaprine hydrochloride 5 MG Oral Tablet — RxCUI 828320

RxNorm drug concept · Semantic clinical drug
RxCUI 828320 Semantic clinical drug · SCD ● Current RxNorm concept 92 FDA products 362 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI828320
Official nameCyclobenzaprine hydrochloride 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascyclobenzaprine HCl 5 MG Oral Tablet
FDA products mapped92
Package NDCs mapped362
Reported Medicaid activity (SDUD)3,934,051 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cyclobenzaprine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a muscle relaxant prescribed to help ease muscle spasms, pain, and stiffness from acute musculoskeletal injuries — like a back strain or a pulled muscle. It's meant to be used...
  • What is cyclobenzaprine actually used for?
  • Yes, drowsiness is one of the most common side effects — it's real and can be significant. You should not drive, operate heavy machinery, or do anything that requires sharp focus u...
  • Will this make me really drowsy? Can I drive?
📖 Read our full Cyclobenzaprine guide →

🕸️ Concept Web — How Cyclobenzaprine hydrochloride 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cyclobenzaprine hydrochloride 5 MG Oral Tablet RxCUI 828320

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cyclobenzaprine 21949
    • Cyclobenzaprine hydrochloride 52101
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cyclobenzaprine Oral Tablet 371661
    • Cyclobenzaprine hydrochloride Oral Tablet 2646945
    • Cyclobenzaprine Oral Product 1156628
    • Cyclobenzaprine Pill 1156629
    • Cyclobenzaprine hydrochloride Oral Product 2660158
    • Cyclobenzaprine hydrochloride Pill 2661873
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cyclobenzaprine hydrochloride 5 MG 828319

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cyclobenzaprine hydrochloride 5 MG SCDC · 828319
  • Cyclobenzaprine Oral Tablet SCDF · 371661
  • Cyclobenzaprine hydrochloride Oral Tablet SCDFP · 2646945
  • Cyclobenzaprine Oral Product SCDG · 1156628
  • Cyclobenzaprine Pill SCDG · 1156629
  • Cyclobenzaprine hydrochloride Oral Product SCDGP · 2660158
  • Cyclobenzaprine hydrochloride Pill SCDGP · 2661873

📦 FDA Products & Package NDCs

92 products · 362 package NDCs
362 package NDCs map to RxCUI 828320 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80425-0016-02 30 TABLET, FILM COATED in 1 BOTTLE (80425-0016-2) Cyclobenzaprine HCL Advanced Rx of Tennessee, LLC 2017-05-31
80425-0016-03 90 TABLET, FILM COATED in 1 BOTTLE (80425-0016-3) Cyclobenzaprine HCL Advanced Rx of Tennessee, LLC 2017-05-31
80425-0016-04 120 TABLET, FILM COATED in 1 BOTTLE (80425-0016-4) Cyclobenzaprine HCL Advanced Rx of Tennessee, LLC 2017-05-31
80425-0017-01 60 TABLET, FILM COATED in 1 BOTTLE (80425-0017-1) Cyclobenzaprine HCL Advanced Rx of Tennessee, LLC 2006-04-04
80425-0155-01 30 TABLET, FILM COATED in 1 BOTTLE (80425-0155-1) Cyclobenzaprine HCL Advanced Rx Pharmacy of Tennessee, LLC 2023-03-30
80425-0155-02 60 TABLET, FILM COATED in 1 BOTTLE (80425-0155-2) Cyclobenzaprine HCL Advanced Rx Pharmacy of Tennessee, LLC 2023-03-30
80425-0155-03 90 TABLET, FILM COATED in 1 BOTTLE (80425-0155-3) Cyclobenzaprine HCL Advanced Rx Pharmacy of Tennessee, LLC 2023-03-30
80425-0155-04 120 TABLET, FILM COATED in 1 BOTTLE (80425-0155-4) Cyclobenzaprine HCL Advanced Rx Pharmacy of Tennessee, LLC 2023-03-30
80425-0155-05 180 TABLET, FILM COATED in 1 BOTTLE (80425-0155-5) Cyclobenzaprine HCL Advanced Rx Pharmacy of Tennessee, LLC 2023-03-30
82461-0714-90 90 TABLET, FILM COATED in 1 BOTTLE (82461-714-90) CYCLOBENZAPRINE HYDROCHLORIDE Medcore LLC 2026-01-11
82461-0716-90 90 TABLET, FILM COATED in 1 BOTTLE (82461-716-90) CYCLOBENZAPRINE HYDROCHLORIDE Medcore LLC 2026-01-11
82868-0008-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (82868-008-30) Cyclobenzaprine Hydrochloride Northwind Health Company, LLC 2024-04-29
Observed labelers: Asclemed USA, Inc. (85) · Bryant Ranch Prepack (53) · Proficient Rx LP (18) · PD-Rx Pharmaceuticals, Inc. (15) · Preferred Pharmaceuticals Inc. (15) · DirectRx (12) · +31 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.